1
|
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.
|
J Peripher Nerv Syst
|
2007
|
2.01
|
2
|
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.
|
J Neurol Neurosurg Psychiatry
|
2013
|
1.55
|
3
|
Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial.
|
Hypertension
|
2011
|
1.54
|
4
|
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
|
Eur J Cancer
|
2010
|
1.50
|
5
|
Chemotherapy-induced neuropathy.
|
Curr Treat Options Neurol
|
2011
|
0.99
|
6
|
Learning disorders in epilepsy.
|
Epilepsia
|
2006
|
0.99
|
7
|
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
|
J Peripher Nerv Syst
|
2008
|
0.86
|
8
|
A review of the costs of managing childhood epilepsy.
|
Pharmacoeconomics
|
2005
|
0.85
|
9
|
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy.
|
Neurol Sci
|
2014
|
0.80
|
10
|
Long-term course of oxaliplatin-induced polyneuropathy: a prospective 2-year follow-up study.
|
J Peripher Nerv Syst
|
2014
|
0.79
|
11
|
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.
|
J Peripher Nerv Syst
|
2014
|
0.77
|
12
|
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue.
|
Pain Manag
|
2013
|
0.75
|
13
|
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study.
|
Neurology
|
2017
|
0.75
|